Basic Information
Basic information for MIR4300HG-210-16aa-2
Peptide Name MIR4300HG-210-16aa-2
Genome Position chr11:81879970-81880017[-]
Species Human
Peptide Sequence MILLESKSSSPSPVFK
Peptide Length 16
Unique No (MIR4300HG-201-16aa-2,MIR4300HG-202-16aa,MIR4300HG-205-16aa-2,MIR4300HG-209-16aa-2,MIR4300HG-213-16aa-2)
Grand Average of Hydropathicity 0.1562
Relative Molecular Mass 2020.28
Experimental Evidences 1:ribo
lncRNA ID/Name ENSG00000245832;MIR4300HG
Transcript ID/Name ENST00000667990;MIR4300HG-210
Transcript Length 1016
Coding Ability 0.4636
DNA Sequence Corresponding to Peptide ATGATTCTTCTTGAAAGTAAATCTTCCAGCCCCAGTCCAGTATTCAAA
Experimental Evidences
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :